Abstract
Introduction: Bronchial asthma is a chronic disorder with high prevalence among women. Visfatin as a pro-inflammatory adipokine has been linked to inflammatory lung diseases such as asthma and can be used as a forthcoming biomarker target to diagnose and treat asthmatic patients.
Aim: The aim of this study is to evaluate plasma visfatin level and its correlation with pulmonary function of female asthmatic patients.
Methods: This cross-sectional study was conducted on all female asthmatic patients referred to the Be'sat Pulmonary Clinic of Kerman from 1 November 2019 to 20 February 2020. Patients with confirmed diagnosis of asthma were included. The data were collected through a checklist and the corresponding author conducted all face-to-face interviews in the physician’s office of the pulmonary clinic. Then, blood samples (5 cc) were taken from the patients to determine the plasma level of visfatin. Data was analyzed by SPSS Software.
Results: 113 women with asthma were studied. The mean ± SD age of patients was 46.71 ± 13.91 years (range: 13 to 75). The mean ± SD of visfatin plasma levels was 26.30 ± 6.98 mg/dl (range: 8.50 to 46.88). The forced expiratory volume in the first second (FEV1) had a significant and negative correlation with plasma visfatin concentrations (P-value = 0.03).
Conclusion: The results of this study indicated that plasma visfatin levels were correlated inversely with FEV1 among asthmatic women. Further studies with large samples are recommended to evaluate the role of visfatin in asthma pathogenesis.
Graphical Abstract
[1]
Nakagome K, Nagata M. Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx 2011; 38(5): 555-63.
[http://dx.doi.org/10.1016/j.anl.2011.01.011] [PMID: 21334836]
[http://dx.doi.org/10.1016/j.anl.2011.01.011] [PMID: 21334836]
[2]
Wei M, Xie X, Chu X, Yang X, Guan M, Wang D. Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model. Immunopharmacol Immunotoxicol 2013; 35(3): 382-9.
[http://dx.doi.org/10.3109/08923973.2013.785559] [PMID: 23635079]
[http://dx.doi.org/10.3109/08923973.2013.785559] [PMID: 23635079]
[3]
To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: Findings from the cross-sectional world health survey. BMC Public Health 2012; 12(1): 204.
[http://dx.doi.org/10.1186/1471-2458-12-204] [PMID: 22429515]
[http://dx.doi.org/10.1186/1471-2458-12-204] [PMID: 22429515]
[4]
Leynaert B, Sunyer J, Garcia-Esteban R, et al. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort. Thorax 2012; 67(7): 625-31.
[http://dx.doi.org/10.1136/thoraxjnl-2011-201249] [PMID: 22334535]
[http://dx.doi.org/10.1136/thoraxjnl-2011-201249] [PMID: 22334535]
[5]
Wijnhoven HAH, Kriegsman DMW, Snoek FJ, Hesselink AE, de Haan M. Gender differences in health-related quality of life among asthma patients. J Asthma 2003; 40(2): 189-99.
[http://dx.doi.org/10.1081/JAS-120017990] [PMID: 12765321]
[http://dx.doi.org/10.1081/JAS-120017990] [PMID: 12765321]
[6]
Sinclair AH, Tolsma DD. Gender differences in asthma experience and disease care in a managed care organization. J Asthma 2006; 43(5): 363-7.
[http://dx.doi.org/10.1080/02770900600705334] [PMID: 16801140]
[http://dx.doi.org/10.1080/02770900600705334] [PMID: 16801140]
[7]
Fu J, McDonald VM, Gibson PG, Simpson JL. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res 2014; 6(4): 316-24.
[http://dx.doi.org/10.4168/aair.2014.6.4.316] [PMID: 24991455]
[http://dx.doi.org/10.4168/aair.2014.6.4.316] [PMID: 24991455]
[8]
Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115(5): 911-9.
[http://dx.doi.org/10.1016/j.jaci.2005.02.023] [PMID: 15867843]
[http://dx.doi.org/10.1016/j.jaci.2005.02.023] [PMID: 15867843]
[9]
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11(2): 85-97.
[http://dx.doi.org/10.1038/nri2921] [PMID: 21252989]
[http://dx.doi.org/10.1038/nri2921] [PMID: 21252989]
[10]
Ali Assad N, Sood A. Leptin, adiponectin and pulmonary diseases. Biochimie 2012; 94(10): 2180-9.
[http://dx.doi.org/10.1016/j.biochi.2012.03.006] [PMID: 22445899]
[http://dx.doi.org/10.1016/j.biochi.2012.03.006] [PMID: 22445899]
[11]
Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178(3): 1748-58.
[http://dx.doi.org/10.4049/jimmunol.178.3.1748] [PMID: 17237424]
[http://dx.doi.org/10.4049/jimmunol.178.3.1748] [PMID: 17237424]
[12]
Revollo JR, Körner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007; 6(5): 363-75.
[http://dx.doi.org/10.1016/j.cmet.2007.09.003] [PMID: 17983582]
[http://dx.doi.org/10.1016/j.cmet.2007.09.003] [PMID: 17983582]
[13]
Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007; 18(3-4): 313-25.
[http://dx.doi.org/10.1016/j.cytogfr.2007.04.007] [PMID: 17507280]
[http://dx.doi.org/10.1016/j.cytogfr.2007.04.007] [PMID: 17507280]
[14]
Xie H, Tang SY, Luo XH, et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007; 80(3): 201-10.
[http://dx.doi.org/10.1007/s00223-006-0155-7] [PMID: 17340225]
[http://dx.doi.org/10.1007/s00223-006-0155-7] [PMID: 17340225]
[15]
Dedoussis GV, Kapiri A, Samara A, Dimitriadis D, Lambert D, Pfister M, et al. Visfatin: The link between inflammation and childhood obesity. Diabetes Care 2009; 32(6): e71.
[http://dx.doi.org/10.2337/dc08-2304]
[http://dx.doi.org/10.2337/dc08-2304]
[16]
Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001; 56(1): 4-8.
[http://dx.doi.org/10.1136/thorax.56.1.4] [PMID: 11120896]
[http://dx.doi.org/10.1136/thorax.56.1.4] [PMID: 11120896]
[17]
Akerman MJH, Calacanis CM, Madsen MK. Relationship between asthma severity and obesity. J Asthma 2004; 41(5): 521-6.
[http://dx.doi.org/10.1081/JAS-120037651] [PMID: 15360059]
[http://dx.doi.org/10.1081/JAS-120037651] [PMID: 15360059]
[18]
Toru Ü, Ayada C, Genç O, et al. Visfatin and ghrelin: can they be forthcoming biomarkers or new drug targets for asthma? Int J Clin Exp Med 2015; 8(4): 6257-61.
[PMID: 26131235]
[PMID: 26131235]
[19]
Camargo CA Jr, Rachelefsky G, Schatz M. Managing asthma exacerbations in the emergency department: summary of the National Asthma Education And Prevention Program Expert Panel Report 3 guidelines for the management of asthma exacerbations. Proc Am Thorac Soc 2009; 6(4): 357-66.
[http://dx.doi.org/10.1513/pats.P09ST2] [PMID: 19675345]
[http://dx.doi.org/10.1513/pats.P09ST2] [PMID: 19675345]
[20]
Eslaminejad A, Taghavi K, Moradpour S, Emami H. Prevalence of Asthma Control in Iran, assessing asthma control test running head: Asthma control in Iran. J Respir Med Lung Dis 2017; 2(5): 1028.
[21]
Sigari N, Sigari N, Ghasri H, Rahimi E, Mohammadi S. Validation of persian version of asthma control test based on new global initiative for asthma guidelines. Tanaffos 2011; 10(4): 49-53.
[PMID: 25191388]
[PMID: 25191388]
[22]
Bagadood R. Impact of obesity on lung inflammation and response to corticosteroids in allergic asthma PhD. Thesis. Leicester: University of Leicester:. 2019.
[23]
Souza ECC, Pizzichini MMM, Dias M, et al. Body mass index, asthma, and respiratory symptoms: A population-based study. J Bras Pneumol 2020; 46(1): e20190006.
[http://dx.doi.org/10.1590/1806-3713/e20190006] [PMID: 31859815]
[http://dx.doi.org/10.1590/1806-3713/e20190006] [PMID: 31859815]
[24]
Ulrik CS, Lophaven SN, Andersen ZJ, Sørensen TIA, Baker J. BMI at school age and incident asthma admissions in early adulthood: A prospective study of 310,211 children. Clin Epidemiol 2018; 10: 605-12.
[http://dx.doi.org/10.2147/CLEP.S156310] [PMID: 29872349]
[http://dx.doi.org/10.2147/CLEP.S156310] [PMID: 29872349]
[25]
Greenblatt R, Mansour O, Zhao E, Ross M, Himes BE. Gender-specific determinants of asthma among U.S. adults. Asthma Res Pract 2017; 3(1): 2.
[http://dx.doi.org/10.1186/s40733-017-0030-5] [PMID: 28138394]
[http://dx.doi.org/10.1186/s40733-017-0030-5] [PMID: 28138394]
[26]
Naeem A, Silveyra P. Sex differences in paediatric and adult asthma. Eur Med J 2019; 4(2): 27-35.
[http://dx.doi.org/10.33590/emj/10312930] [PMID: 31328173]
[http://dx.doi.org/10.33590/emj/10312930] [PMID: 31328173]
[27]
Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, et al. Serum concentration of visfatin in obese women. Metabolism 2007; 56(8): 1131-4.
[http://dx.doi.org/10.1016/j.metabol.2007.04.007] [PMID: 17618961]
[http://dx.doi.org/10.1016/j.metabol.2007.04.007] [PMID: 17618961]
[28]
Stastny J, Bienertova-Vasku J, Vasku A. Visfatin and its role in obesity development. Diabetes Metab Syndr 2012; 6(2): 120-4.
[http://dx.doi.org/10.1016/j.dsx.2012.08.011] [PMID: 23153983]
[http://dx.doi.org/10.1016/j.dsx.2012.08.011] [PMID: 23153983]
[29]
Jin H, Jiang B, Tang J, et al. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res Clin Pract 2008; 79(3): 412-8.
[http://dx.doi.org/10.1016/j.diabres.2007.09.019] [PMID: 18241953]
[http://dx.doi.org/10.1016/j.diabres.2007.09.019] [PMID: 18241953]
[30]
Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008; 63(1): 14-20.
[http://dx.doi.org/10.1136/thx.2007.082784] [PMID: 18156567]
[http://dx.doi.org/10.1136/thx.2007.082784] [PMID: 18156567]
[31]
Varraso R, Siroux V, Maccario J, Pin I, Kauffmann F. Asthma severity is associated with body mass index and early menarche in women. Am J Respir Crit Care Med 2005; 171(4): 334-9.
[http://dx.doi.org/10.1164/rccm.200405-674OC] [PMID: 15557134]
[http://dx.doi.org/10.1164/rccm.200405-674OC] [PMID: 15557134]
[32]
Zein JG, Erzurum SC. Asthma is different in women. Curr Allergy Asthma Rep 2015; 15(6): 28.
[http://dx.doi.org/10.1007/s11882-015-0528-y] [PMID: 26141573]
[http://dx.doi.org/10.1007/s11882-015-0528-y] [PMID: 26141573]
[33]
Boulet LP. Asthma and obesity. Clin Exp Allergy 2013; 43(1): 8-21.
[http://dx.doi.org/10.1111/j.1365-2222.2012.04040.x] [PMID: 23278876]
[http://dx.doi.org/10.1111/j.1365-2222.2012.04040.x] [PMID: 23278876]
[34]
Machura E, Ziora K, Ziora D, et al. Serum visfatin levels are decreased in schoolchildren with atopic asthma. Neuroendocrinol Lett 2012; 33(5): 559-64.
[PMID: 23090276]
[PMID: 23090276]
[35]
Tsaroucha A, Daniil Z, Malli F, et al. Leptin, adiponectin, and ghrelin levels in female patients with asthma during stable and exacerbation periods. J Asthma 2013; 50(2): 188-97.
[http://dx.doi.org/10.3109/02770903.2012.747101] [PMID: 23259727]
[http://dx.doi.org/10.3109/02770903.2012.747101] [PMID: 23259727]
[36]
Temprano J, Mannino DM. The effect of sex on asthma control from the National Asthma Survey. J Allergy Clin Immunol 2009; 123(4): 854-60.
[http://dx.doi.org/10.1016/j.jaci.2008.12.009] [PMID: 19181370]
[http://dx.doi.org/10.1016/j.jaci.2008.12.009] [PMID: 19181370]
[37]
Lisspers K, Ställberg B, Janson C, Johansson G, Svärdsudd K. Sex-differences in quality of life and asthma control in Swedish asthma patients. J Asthma 2013; 50(10): 1090-5.
[http://dx.doi.org/10.3109/02770903.2013.834502] [PMID: 23947390]
[http://dx.doi.org/10.3109/02770903.2013.834502] [PMID: 23947390]
[38]
McCallister JW, Holbrook JT, Wei CY, et al. Sex differences in asthma symptom profiles and control in the American Lung Association Asthma Clinical Research Centers. Respir Med 2013; 107(10): 1491-500.
[http://dx.doi.org/10.1016/j.rmed.2013.07.024] [PMID: 23972381]
[http://dx.doi.org/10.1016/j.rmed.2013.07.024] [PMID: 23972381]
[39]
Campos FL, de Bruin PFC, Pinto TF, da Silva FGC, Pereira EDB, de Bruin VMS. Depressive symptoms, quality of sleep, and disease control in women with asthma. Sleep & breathing = Schlaf & Atmung 2017; 21(2): 361-7.
[http://dx.doi.org/10.1007/s11325-016-1422-0]
[http://dx.doi.org/10.1007/s11325-016-1422-0]
[40]
Andrianasolo RM, Kesse-Guyot E, Adjibade M, Hercberg S, Galan P, Varraso R. Associations between dietary scores with asthma symptoms and asthma control in adults. Eur Respir J 2018; 52(1): 1702572.
[http://dx.doi.org/10.1183/13993003.02572-2017] [PMID: 29997182]
[http://dx.doi.org/10.1183/13993003.02572-2017] [PMID: 29997182]
[41]
Chwalba A, Machura E, Ziora K, Ziora D. The role of adipokines in the pathogenesis and course of selected respiratory diseases. Endokrynol Pol 2019; 70(6): 504-10.
[http://dx.doi.org/10.5603/EP.a2019.0051] [PMID: 31891413]
[http://dx.doi.org/10.5603/EP.a2019.0051] [PMID: 31891413]
[42]
Liu X, Ji Y, Chen J, Li S, Luo F. Circulating visfatin in chronic obstructive pulmonary disease. Nutrition 2009; 25(4): 373-8.
[http://dx.doi.org/10.1016/j.nut.2008.09.008] [PMID: 19056239]
[http://dx.doi.org/10.1016/j.nut.2008.09.008] [PMID: 19056239]
[43]
Zhang A-L, Xing R, Li N. Circulating visfatin level and its relation with TNF-α and nutritional status in patients with chronic obstructive pulmonary diseases. Chinese J Difficult Compl Cases 2011; (7): 13.
[44]
Leivo-Korpela S, Lehtimäki L, Hämälainen M, et al. Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease. Mediators Inflamm 2014; 2014: 1-6.
[http://dx.doi.org/10.1155/2014/232167] [PMID: 24891763]
[http://dx.doi.org/10.1155/2014/232167] [PMID: 24891763]
[45]
Romacho T, Villalobos LA, Cercas E, Carraro R, Sánchez-Ferrer CF, Peiró C. Visfatin as a novel mediator released by inflamed human endothelial cells. PLoS One 2013; 8(10): e78283.
[http://dx.doi.org/10.1371/journal.pone.0078283] [PMID: 24130902]
[http://dx.doi.org/10.1371/journal.pone.0078283] [PMID: 24130902]
[46]
Liu P, Li H, Cepeda J, et al. Critical role of PBEF expression in pulmonary cell inflammation and permeability. Cell Biol Int 2009; 33(1): 19-30.
[http://dx.doi.org/10.1016/j.cellbi.2008.10.015] [PMID: 18996492]
[http://dx.doi.org/10.1016/j.cellbi.2008.10.015] [PMID: 18996492]
[47]
Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364(9435): 709-21.
[http://dx.doi.org/10.1016/S0140-6736(04)16900-6] [PMID: 15325838]
[http://dx.doi.org/10.1016/S0140-6736(04)16900-6] [PMID: 15325838]
Related Journals
